Treatment of Tinea Infections: Dosing and Drug Selection
For tinea infections, oral terbinafine is the first-line treatment for Trichophyton species (250 mg daily for 2-4 weeks), while griseofulvin is preferred for Microsporum infections (10 mg/kg daily for 2-4 weeks in children; 500 mg daily for 2-4 weeks in adults). 1
Drug Selection Based on Causative Organism
First-line Treatment Options:
Trichophyton species infections:
Microsporum species infections:
Treatment Duration by Infection Type:
- Tinea corporis (body): 2-4 weeks 3, 4
- Tinea cruris (groin): 2 weeks 4, 5
- Tinea pedis (feet): 4-8 weeks with azoles; 1-2 weeks with allylamines 4, 6
- Tinea capitis (scalp): 4-6 weeks 3
- Tinea unguium (nails): At least 4 months for fingernails; 6+ months for toenails 3
Second-line Treatment Options:
If first-line treatment fails, consider:
- 100 mg daily for 2 weeks or 200 mg daily for 7 days
- Effective against both Trichophyton and Microsporum species
Fluconazole: 5
- 50-100 mg daily or 150 mg once weekly for 2-3 weeks for tinea corporis/cruris
- 150 mg once weekly for tinea pedis
Important Clinical Considerations:
Monitoring and Follow-up:
- Continue treatment for at least one week after clinical clearing of infection 4
- The endpoint should be mycological cure, not just clinical improvement 1, 7
- Perform follow-up mycological examination in resistant cases 7
Adjunctive Measures:
- Topical therapy alone is not recommended for extensive infections but can be used as adjunctive treatment 1
- General hygiene measures should be observed to control sources of reinfection 3
- For anthropophilic infections, consider screening and treating family members 7
Common Pitfalls:
Incorrect diagnosis: Accurate diagnosis through direct microscopy of infected tissue in potassium hydroxide solution or culture is essential before starting treatment 3, 4
Inadequate treatment duration: Treatment should continue until the infecting organism is completely eradicated 3
Failure to address contributing factors: Skin moisture and other exacerbating factors must be addressed 4
Drug interactions: Be aware that terbinafine inhibits CYP2D6 and can affect metabolism of other medications 2, while itraconazole has significant interactions with antihistamines, antipsychotics, anxiolytics, and other medications 7
Hepatotoxicity risk: Monitor liver function with oral antifungal therapy, particularly with ketoconazole 7
The choice between oral and topical therapy depends on the extent and location of infection. For limited, uncomplicated tinea infections, topical therapy may be sufficient. However, for extensive, inflammatory, or resistant cases, oral therapy as outlined above is recommended.